Autopsy report · NCT00209664
Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer
Cause of deathNo reason given
Life of this trial
- Registered 1 year 8 months after it had already started.
- Suspended: paused, and may or may not restart.
- 40 participants enrolled.
Vital statistics
- Status
- Suspended
- Phase
- Phase 2
- Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Sponsor type
- University, hospital or other
- Conditions
- Gastric Cancer
- Interventions
- irinotecan; S-1
- Participants
- 40
- Sites
- 1
- Countries
- Japan
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.